HSE issues vapes alert on six e-cigarettes falsely labelled as nicotine-free
The six e-cigarettes were found to contain nicotine at concentrations as high as 30 mg/ml following analysis by the State Laboratory — far above the legal concentration level for nicotine vapes.
Anyone who bought one of the six vapes listed below can return them to the shop where they were bought. Vape shops and retailers have been asked to stop selling them.
They are:
McKesse MK Bar 7000. Sub-brand (flavour): Blueberry
McKesse MK Bar 7000. Sub-brand (flavour): Blackcurrant Mango
McKesse MK Bar 7000. Sub-brand (flavour): Blueberry Pear
Bang Box 18000 Puffs. Sub-brand (flavour): Watermelon Ice
Bang Box 18000 Puffs. Sub-brand (flavour): Strawberry Watermelon
Bang Box 18000 Puffs. Sub-brand (flavour): Blueberry Ice
HSE Principal Environmental Health Officer, Margaret Ruddy, warned: 'We are continuing to identify non-compliant products on the Irish market.'
The Bang Box Watermelon Ice.
Analysis showed in these cases that the nicotine concentration ranged from 18.8 mg/ml to 30 mg/ml. The legal concentration level for nicotine-containing vapes is 20mg/ml.
'Retailers should be checking both the products themselves and their suppliers' details before selling them on to consumers,' she said. 'Otherwise, they may not only be putting the consumer at risk, they may be breaking the law and making it more difficult to trace and seek the recall and withdrawal of dangerous batches of such products.'
Anyone who became ill after using these e-cigarettes should contact their GP. They can also notify the HSE by email at info.tpd@hse.ie.
The HSE has also alerted shops which may have sold these vapes to display a recall notice. Shops are advised: 'By law, you are responsible for non-compliant products found in your shop.'
Regulations
In Ireland it is already illegal to sell vapes to under-18s. Proposals for further regulations are now being drafted with the Attorney General, a Department of Health spokeswoman said.
The proposals include a ban on all disposable vapes and a ban on devices resembling toys or games. It would mean a ban on point-of-sale display and advertising of nicotine-inhaling products in most shops.
The legislation is expected to also include restrictions on the colours and imagery used on nicotine-inhaling products and their packaging. It could bring in significant limits on the flavours for sale and requirements for only basic flavour names to be used.
It could lead to only tobacco-flavoured vapes being sold here as is already the case in some European countries. 'The upcoming Public Health (Nicotine Inhaling Products) Bill is designed to address the rise in youth use of vapes in Ireland,' the department spokeswoman said.
She also highlighted growing concerns that the decline in use of tobacco products, including cigarettes in Ireland, has slowed. The figures have not really moved since 2019, separate data shows.
'The stalled decline in smoking among adults is of significant concern,' she said. 'Last year, the Oireachtas passed legislation to raise the age of sale for tobacco products to 21 years, as a direct response to this issue.
'The Tobacco Free Ireland policy is also currently under review, to examine what measures need to be taken for Ireland to become tobacco-free.'
Read More
Vaping has led a surge of young people using nicotine/tobacco products
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Irish Independent
10 hours ago
- Irish Independent
Three companies paid €71m to reduce hospital waiting lists – one of which received more than €54m, HSE figures reveal
One of the companies was paid in the region €54.6m, according to the figures provided to the Oireachtas health committee. The other two were each paid €10m and over €5m. The figures supplied to the committee come after HSE chief Bernard Gloster said earlier this week it was planned to phase out of the use of these companies over the next year. They are hired by hospitals and the wider health service to help reduce waiting list backlogs. He told the health committee that a trawl carried out by the HSE covering 27 months found around €100m in total was paid out to these companies during that time employing the external companies to carry out waiting list work using public facilities in the evenings and weekends. The HSE review – which followed recent controversies – also shows that 83 directors of these companies are current or previous employees of the HSE. Some 23 are current employees – working in the HSE while also serving as directors of companies hired by hospitals to reduce backlogs of waiting list patients. He told the committee earlier this week he planned to phase out this form of insourcing in public hospitals by the end of June this year and it was not possible to do it immediately. These companies have grown in 'level and scale. We took our eye off the ball. We need to unwind it,' he told the committee. He add that the 'only way to change it is to stop it.' The winding down must be done 'sensibly', he added. He pointed out there is nothing unlawful about being a company director and there are obligations under the Standards in Public Office or employment contract terms. The review had found an over-reliance on these external companies – several of which had links to hospitals. He said the plan is to introduce more safeguards around them and he is to work with Health Minister Jennifer Carroll MacNeill on strengthening these. The review examined 148 companies which had 365 directors in total and found 93 matches with current or previous HSE employees. The implications for removing these companies from carrying out the work is that there is potential for having to use more private hospitals to treat public patients. The aim is to increase productivity through routine work.
Irish Examiner
13 hours ago
- Irish Examiner
Only 10% of people with ADHD have been assessed or treated, says charity
As little as 10% of people with ADHD in Ireland are prescribed with medication, despite a surge in demand. Ken Kilbride, the chief executive of ADHD Ireland, acknowledged an increase in prescribing but cautioned that it is from a very low base. A total of 25,715 patients were prescribed medication for ADHD on the medical card, or other public health schemes last year, compared to 10,327 in 2020, information released under the Freedom of Information Act showed. However, this needs to be compared with an estimated 5% prevalence rate for ADHD in Ireland, Mr Kilbride cautioned. 'There's probably about 250,000 people in Ireland that do have ADHD, so 25,000 taking medication is only 10%,' he said. 'We've gone from few thousand people up to 10% but there's still 90% that haven't been assessed or treated. Good start, more to do.' Non-medical management is usually the first step, he explained, and then medication in parallel with this, if necessary. There are private psychiatrists also supporting ADHD patients, but he said: 'There's only a handful to be honest.' Dublin South East had the most patients receiving reimbursements for ADHD medicines under the drug payment scheme at 1,261. 'They would have opened up a clinic there in the last couple of years, and the clinic got overwhelmed in terms of the number of people coming through it,' he said. 'They're not taking new referrals, and that clinic might be part of the Local Health Offices in Dublin South East.' In contrast, the data showed just 79 prescriptions on medical cards last year in West Cork, the lowest nationally. While there is a clinic in Cork City, he said: 'People living in West Cork are that little bit further out, so they're likely not getting into see them.' He added the figure of 79 is 'absolutely not' reflective of the likely true number there. Camhs He also raised concerns about waiting times for Child & Adolescent Mental Health Services (Camhs) in Cork and Kerry, also released under the Freedom of Information Act. It is accepted many of these children are waiting for ADHD assessment. 'At the top of the list children waiting 15 to 18 months make up about 70% to 80%, so people aren't getting seen quickly,' he warned. 'Why are people waiting this long? It is an indication of the lack of staffing in the service. The HSE will say we have moved this up the priority list.' He added: 'They have reduced the waiting lists but there's still more people on it now than two years ago because there's more people coming into the system.' Read More Cork and Kerry mental health services have fewer staff now than during staffing crisis two years ago
The Journal
15 hours ago
- The Journal
'Laughing gas' leak reported at Limerick hospital months before faulty system was shut down
A SUBSTANTIAL, ONGOING leak of nitrous oxide was detected at St. John's Hospital in Limerick last year – months before it was announced that the system was being decommissioned 'as a response to global warming'. Long-term exposure to nitrous oxide or 'laughing gas' can damage the body's nervous system and red blood cells, leading to a number of serious neurological conditions, as well as increasing the risk of certain liver and kidney diseases. During a seven-month audit carried out at the hospital last year, a substantial depletion of nitrous oxide supplies was recorded, despite the fact that there had been no clinical use of the gas in that period. A spokesman for the Health Service Executive (HSE) claimed that a leak in the piped supply of the anaesthetic gas was first detected in October 2024. However, records released under freedom of information laws show that management was informed of 'an ongoing leak' by a consultant anaesthetist in an email dated 2 September. In the same correspondence, the consultant also suggested that a nitrous oxide leak was also ongoing at University Hospital Limerick (UHL). On 31 October, the consultant described the leak as 'substantial' and said it was hoped to switch off the piped supply over Christmas, transitioning to the use of mobile nitrous oxide cylinders attached directly to anaesthetic machines. Advertisement On 11 November, another consultant anaesthetist advised management that the piped nitrous oxide supply should be turned off, 'keeping in mind the losses that have been reported'. The piped supply was finally decommissioned on 16 April, 2025, according to the HSE. This was celebrated as part of an environmental strategy in a press release by the HSE in May, which said St. John's Hospital was 'in the vanguard of the global effort to reduce global emissions'. Nitrous oxide is commonly used as pain relief during childbirth, though recreational use of the drug has risen in recent years, with the HSE Adolescent Addiction Service reporting a 175% increase in a recent 12-month period. However, a HSE spokesman said there was 'no evidence' that the loss of nitrous oxide at St. John's Hospital had been used or taken off site for recreational purposes. He said the hospital was among the first in the country to discontinue the use of piped nitrous oxide as a response to global warming. 'Detected initially in October 2024, [the leak] was in line with expectations for piped systems in hospitals, and there is no evidence to suggest that it posed any risk to patients or staff,' he added. 'There was no leak detected in clinical spaces where nitrous oxide was used. The HSE's Climate Action Strategy has targeted a 50% decrease in emissions from anaesthetic gases by 2030. 'While nitrous oxide is safe to use, the piped infrastructure traditionally used to deliver it inevitably results in waste, hence the global effort to reduce emissions, of which St. John's Hospital has been in the vanguard,' added the spokesman. Readers like you are keeping these stories free for everyone... A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article. Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation. Learn More Support The Journal
